Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors

Cell

Volumn 114, Issue 3, 2003, Pages 359-370

  Bassing, Craig H ^a   Suh, Heikyung ^a   Ferguson, David O ^a,c   Chua, Katrin F ^a   Manis, John ^a   Eckersdorff, Mark ^a   Gleason, Megan ^a   Bronson, Rodrick ^b   Lee, Charles ^c   Alt, Frederick W ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b TUFTS UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; HISTONE H2A; HISTONE H2AX; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CHROMATIN; CHROMOSOME 12; CHROMOSOME 15; CLONAL VARIATION; CONTROLLED STUDY; CYTOGENETICS; DNA REPAIR; DNA STRAND BREAKAGE; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENE TARGETING; GENE TRANSLOCATION; GENETIC RECOMBINATION; GENETIC STABILITY; HAPLOIDY; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; PROTEIN VARIANT; SOLID TUMOR; T CELL LYMPHOMA; THYMUS LYMPHOMA;

ANIMALIA;

EID: 0042991379     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00566-X     Document Type: Article

References (53)

1. Anderson G., Hare K.J., Jenkinson E.J. Positive selection of thymocytes. the long and winding road Immunol. Today. 20:1999;463-468.
2. Bachelier R., Xu X., Wang X., Li W., Naramura M., Gu H., Deng C.X. Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice. Oncogene. 22:2003;528-537.
3. Bassing C.H., Chua K.F., Sekiguchi J., Suh H., Whitlow S.R., Fleming J.C., Monroe B.C., Ciccone D.N., Yan C., Vlasakova K.et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc. Natl. Acad. Sci. USA. 99:2002;8173-8178. a.
4. Bassing C.H., Swat W., Alt F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 109(Suppl):2002;S45-S55. b.
5. Bosco G., Haber J.E. Chromosome break-induced DNA replication leads to nonreciprocal translocations and telomere capture. Genetics. 150:1998;1037-1047.
6. Brown E.J., Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 17:2003;615-628.
7. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276:2001;42462-42467.
8. Casper A.M., Nghiem P., Arlt M.F., Glover T.W. ATR regulates fragile site stability. Cell. 111:2002;779-789.
9. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J.et al. Genomic instability in mice lacking histone H2AX. Science. 296:2002;922-927.
10. Celeste A., Difilippantonio S., Difilippantonio M.J., Fernandez-Capetillo O., Pilch D.R., Sedelnikova O.A., Eckhaus M., Ried T., Bonner W.M., Nussenzweig A. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell. 114:2003;371-383., this issue.
11. Chen H.T., Bhandoola A., Difilippantonio M.J., Zhu J., Brown M.J., Tai X., Rogakou E.P., Brotz T.M., Bonner W.M., Ried T., Nussenzweig A. Response to RAG-mediated VDJ cleavage by NBS1 and γ-H2AX. Science. 290:2000;1962-1965.
12. Cherif D., Bernard O., Paulien S., James M.R., Le Paslier D., Berger R. Hunting 11q23 deletions with fluorescence in situ hyridization (FISH). Leukemia. 8:1994;578-586.
13. Cogne M., Lansford R., Bottaro A., Zhang J., Gorman J., Young F., Cheng H.L., Alt F.W. A class switch control region at the 3′ end of the immunoglobulin heavy chain locus. Cell. 77:1994;737-747.
14. Difilippantonio M.J., Petersen S., Chen H.T., Johnson R., Jasin M., Kanaar R., Ried T., Nussenzweig A. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 196:2002;469-480.
15. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
16. Downs J.A., Lowndes N.F., Jackson S.P. A role for Sacchromyces cerevisiae histone H2A in DNA repair. Nature. 408:2000;1001-1004.
17. Fernandez-Capetillo O., Chen H.T., Celeste A., Ward I., Romanienko P.J., Morales J.C., Naka K., Xia Z., Camerini-Otero R.D., Motoyama N.et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat. Cell Biol. 4:2002;993-997.
18. Fernandez-Capetillo O., Mahadevaiah S.K., Celeste A., Romanienko P.J., Camerini-Otero R.D., Bonner W.M., Manova K., Burgoyne P., Nussenzweig A. H2AX Is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. Dev. Cell. 4:2003;497-508.
19. Fodde R., Smits R. A matter of dosage. Science. 298:2002;761-763.
20. Furuta T., Takemura H., Liao Z.Y., Aune G.J., Redon C., Sedelnikova O.A., Pilch D.R., Rogakou E.P., Celeste A., Chen H.T.et al. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA-double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J. Biol. Chem. 278:2003;20303-20312.
21. Gladdy R.A., Taylor M.D., Williams C.J., Grandal I., Karaskova J., Squire J.A., Rutka J.T., Guidos C.J., Danska J.S. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell. 3:2003;37-50.
22. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., Jackson S.P. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 421:2003;952-956.
23. Harvey M., McArthur M.J., Montgomery C.A. Jr., Bradley A., Donehower L.A. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7:1993;938-943.
24. Hirao A., Cheung A., Duncan G., Girard P.M., Elia A.J., Wakeham A., Okada H., Sarkissian T., Wong J.A., Sakai T.et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol. Cell. Biol. 22:2002;6521-6532.
25. Jack M.T., Woo R.A., Hirao A., Cheung A., Mak T.W., Lee P.W. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response. Proc. Natl. Acad. Sci. USA. 99:2002;9825-9829.
26. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1994;1-7.
27. Jackson S.P. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 23:2002;687-696.
28. Knudson A.G. Jr. Mutation and cancer. statistical study of retinoblastoma Proc. Natl. Acad. Sci. USA. 68:1971;820-823.
29. Liao M.J., Zhang X.X., Hill R., Gao J., Qumsiyeh M.B., Nichols W., Van Dyke T. No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol. Cell. Biol. 18:1998;3495-3501.
30. Liyanage M., Weaver Z., Barlow C., Coleman A., Pankratz D.G., Anderson S., Wynshaw-Boris A., Ried T. Abnormal rearrangement within the α/δ T-cell receptor locus in lymphomas from Atm-deficient mice. Blood. 96:2000;1940-1946.
31. Lou Z., Minter-Dykhouse K., Wu X., Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature. 421:2003;957-961.
32. Mahadevaiah S.K., Turner J.M., Baudat F., Rogakou E.P., de Boer P., Blanco-Rodriguez J., Jasin M., Keeney S., Bonner W.M., Burgoyne P.S. Recombinational DNA double-strand breaks in mice precede synapsis. Nat. Genet. 27:2001;271-276.
33. Mak T.W., Hakem A., McPherson J.P., Shehabeldin A., Zablocki E., Migon E., Duncan G.S., Bouchard D., Wakeham A., Cheung A.et al. Brca1 required for T cell lineage development but not TCR loci rearrangement. Nat. Immunol. 1:2000;77-82.
34. Manis J.P., Tian M., Alt F.W. Mechanism and control of class-switch recombination. Trends Immunol. 23:2002;31-39.
35. Mills K.D., Ferguson D.O., Alt F.W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194:2003;77-95.
36. Monteiro A.N., Zhang S., Phelan C.M., Narod S.A. Absence of constitutional H2AX gene mutations in 101 hereditary breast cancer families. J. Med. Genet. 40:2003;e51.
37. Nottenburg C., St. John T., Weissman I.L. Unusual immunoglobulin DNA sequences from the nonexpressed chromosome of mouse normal B lymphocytes. implications for allelic exclusion and the DNA rearrangement process J. Immunol. 139:1987;1718-1726.
38. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:2000;886-895.
39. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R.et al. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature. 414:2001;660-665.
40. Rappold I., Iwabuchi K., Date T., Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell Biol. 153:2001;613-620.
41. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:1998;5858-5868.
42. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146:1999;905-916.
43. Schaffner C., Stilgenbauer S., Rappold G.A., Dohner H., Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood. 94:1999;748-753.
44. Schultz L.B., Chehab N.H., Malikzay A., Halazonetis T.D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151:2000;1381-1390.
45. Sleckman B.P., Bardon C.G., Ferrini R., Davidson L., Alt F.W. Function of the TCRα enhancer in αβ and γδ T cells. Immunity. 7:1997;505-515.
46. Smogorzewska A., Karlseder J., Holtgreve-Grez H., Jauch A., de Lange T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 12:2002;1635-1644.
47. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature. 421:2003;961-966.
48. Stilgenbauer S., Winkler D., Ott G., Schaffner C., Leopolt E., Bentz M., Moller P., Muller-Hermelink H.K., James M.R., Lichter P., Dohner H. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood. 94:1999;3262-3264.
49. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310.
50. Wang B., Matsuoka S., Carpenter P.B., Elledge S.J. 53BP1, a mediator of the DNA damage checkpoint. Science. 298:2002;1435-1438.
51. Ward I.M., Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276:2001;47759-47762.
52. Ward I.M., Minn K., van Deursen J., Chen J. p53 binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol. Cell. Biol. 23:2003;2556-2563.
53. Zhu C., Mills K.D., Ferguson D.O., Lee C., Manis J., Fleming J., Gao Y., Morton C.C., Alt F.W. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell. 109:2002;811-821.